Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Myeloid 2Thoracic 1Sarcoma 1Head & Neck 1Gastrointestinal 1CNS 1

Conditions

Myelodysplastic Syndromes 361Leukemia, Myeloid, Acute 302Myeloproliferative Disorders 155Leukemia, Myelogenous, Chronic, BCR-ABL Positive 142Precursor Cell Lymphoblastic Leukemia-Lymphoma 115Primary Myelofibrosis 103Leukemia, Myelomonocytic, Chronic 89Lymphoma, Non-Hodgkin 76Leukemia 71Polycythemia Vera 64Multiple Myeloma 55Hodgkin Disease 50Hematologic Neoplasms 49Leukemia, Lymphocytic, Chronic, B-Cell 44Leukemia, Biphenotypic, Acute 41Thrombocythemia, Essential 40Lymphoma 40Myelodysplastic-Myeloproliferative Diseases 32Neoplasms 29Leukemia, Myeloid, Chronic-Phase 28Anemia, Refractory, with Excess of Blasts 24Recurrence 23Anemia, Aplastic 21Lymphoma, Mantle-Cell 20Lymphoma, Follicular 20Hematologic Diseases 20Burkitt Lymphoma 20Blastic Plasmacytoid Dendritic Cell Neoplasm 20Blast Crisis 20Histiocytosis, Langerhans-Cell 19

Interventions

Panitumumab 1IFL protocol 1Gemcitabine 1Cetuximab 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Histiocytosis × Myeloid × 1 year × Clear all
NCT05786924 2026-04-21

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Servier

Phase 1/2 Recruiting
554 enrolled
CNSGastrointestinalHead & NeckMyeloidThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Histiocytosis

NCT05915208 2025-06-11

Histiocytic Disorder Follow-up Study

University of Alabama at Birmingham

Recruiting
6,000 enrolled
MyeloidSarcoma

Histiocytosis, Langerhans-Cell, Histiocytosis, Histiocytosis, Sinus, Neoplasms, Second Primary, Erdheim-Chester Disease, Histiocytic Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡